TRAD CHI MED Announces 2025 Annual Report Release and Transition to Full E-Communication

Bulletin Express
04/28

On 29 April 2026, China Traditional Chinese Medicine Holdings Co. Limited (“TRAD CHI MED”) published its 2025 Annual Report. English and Chinese versions are available on both the company website (www.china-tcm.com.cn) and HKEXnews (www.hkexnews.hk). Registered shareholders who previously opted for printed materials have already been sent hard copies.

In line with the paperless listing regime introduced under HKEX Listing Rules 2.07A and 2.07B (effective 31 December 2023), the board confirmed that all future corporate communications will be disseminated electronically. Shareholders will receive a notice of publication by post or email, depending on their selected preference.

The company is actively soliciting shareholders’ email addresses to ensure timely delivery of: 1) Email notifications when new corporate communications are posted online; and 2) All future “Actionable Corporate Communications” (i.e., documents requiring shareholder instructions).

Key operational details include: • Shareholders can submit or update their email via a personalized QR code or by returning the enclosed reply form to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited, at 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai. • If no functional email is provided, the registrar will continue to send printed actionable documents and postal notifications until an email address is supplied. • A request for printed copies remains valid for one year from the date of instruction and can be renewed. Printed materials will be dispatched free of charge upon request. • Enquiries can be directed to the company hotline on (852) 2854 3393 during business hours, Monday to Friday.

The notice was authorized for issue by Chairman Mr. Yang Jun and underscores TRAD CHI MED’s commitment to streamline shareholder communications while aligning with regulatory mandates for electronic disclosure.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10